Trial Profile

A Retrospective Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension (BLIS) on Opioid Use, Hospital Length of Stay, Discharge Status and Hospitalization Costs in Patients Undergoing Total Hip Arthroplasty (THA) at High Use Hospitals

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 May 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Apr 2026 According to a Pacira BioSciences media release, the data from the trial were presented at the Annual Regional Anesthesiology and Acute Pain Medicine Meeting, hosted by the American Society of Regional Anesthesia and Pain Medicine (ASRA) 2026
27 Apr 2026 Results presented in the Pacira BioSciences media release.
12 Jun 2019 Primary endpoint (Home discharge status: BLIS compared to control (in both the Medicare and commercial insurance groups)) has been met, according to results presented in a Pacira BioSciences media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com